Enterovirus, mycoplasma and other infections as predictors for myocardial infarction

Journal of Internal Medicine

Volumn 252, Issue 5, 2002, Pages 421-429

  Reunanen, Antti ^a   Roivainen, M ^a   Kleemola, M ^a   Saikku, P ^a   Leinonen, M ^a   Hovi, T ^a   Knekt, P ^a   Leino, A ^b,c   Aromaa, A ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b SOCIAL INSURANCE INSTITUTION   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chlamydia; Coronary disease; Entero virus; Longitudinal study; Mycoplasma; Risk factors

Indexed keywords

ACUTE PHASE PROTEIN; CD79B ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; ANTIBODY TITER; ARTICLE; CASE CONTROL STUDY; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DEATH; ENTEROVIRUS; FOLLOW UP; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; ACUTE PHASE RESPONSE; CHLAMYDIASIS; CYTOMEGALIC INCLUSION BODY DISEASE; ENTEROVIRUS INFECTION; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MYCOPLASMA PNEUMONIA; PROSPECTIVE STUDY; VIROLOGY; VIRUS INFECTION;

ACUTE-PHASE REACTION; ADENOVIRIDAE INFECTIONS; CASE-CONTROL STUDIES; CHLAMYDIA INFECTIONS; CYTOMEGALOVIRUS INFECTIONS; ENTEROVIRUS INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PNEUMONIA, MYCOPLASMA; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036879454     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.01052.x     Document Type: Article

References (38)

1. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis. Emerging mechanistic paradigms. Circulation 1999; 100: e20-8.
2. Valtonen VV. Role of infection in atherosclerosis. Am Heart J 1999; 138: S431-3.
3. Saikku P. Epidemiology of Chlamydia pneumoniae in atherosclerosis. Am Heart J 1999; 138: S500-3.
4. Leinonen M, Saikku P. Infections anal atherosclerosis. Scand Cardiovasc J 2000; 34: 12-20.
5. Roivainen M, Alfthan G, Jousilahti P, Kimpimaki M, Hovi T, Tuomilehto J. Enterovirus infections as a possible risk factor for myocardial infarction. Circulation 1998; 98: 2534-7.
6. Roivainen M, Viik-Kajander M, Palosuo T, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000; 101: 252-7.
7. Roivainen M. Enteroviruses and myocardial infarction. Am Heart J 1999; 138: S479-83.
8. Knekt P, Reunanen A, Alfthan G, et al. Hyperhomocysteinemia - a risk factor or a consequence of coronary heart disease? Arch Intern Med 2001; 161: 1589-94.
9. Reunanen A, Aromaa A, PyöräläK, Punsar S, Maatela J, Knekt P. The Social Insurance Institution's Coronary Heart Disease Study. Baseline data and 5-year mortality experience. Acta Med Scand 1983; Suppl. 673: 1-120.
10. Aromaa A. Kohonnut verenpaine ja sen kansanterveydellinen merkitys (English summary: epidemiology and public health impact of high blood pressure in Finland) Helsinki: Publications of the Social Insurance Institution, AL: 17, 1981.
11. Heliövaara M, Reunanen A, Aromaa A, Knekt P, Aho K, Suhonen O. Validity of hospital discharge data in prospective epidemiological study on stroke and myocardial infarction. Acta Med Scand 1984; 216: 309-15.
12. Knekt P. Serum Alpha-tocopherol and the Risk of Cancer. Helsinki: Publications of the Social Insurance Institution, ML: 83, 1988.
13. Hovi T, Roivainen M. Peptide antisera targeted to a conserved sequence in poliovirus capsid protein VP1 cross-react widely with members of the genus enterovirus. J Clin Microbiol 1993; 31: 1083-7.
14. Samuelsson A, Cello J, Skoog E, Glimåker M, Jeansson S, Forsgren M. Enterovirus IgG ELISA using synthetic peptides as antigens. Serodiag Immunother Infect Dis 1993; 5: 93-6.
15. Davidkin I, Valle M, Peltola H, et al. Etiology of measles- and rubella-like illnesses in measles, mumps and rubella vaccinated children. J Inf Dis 1998; 178: 1567-70.
16. Ekman MR, Grayston JT, Visakorpi R, Kleemola M, Kuo CC, Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993; 17: 420-5.
17. Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Presence of Chlamydia pneumoniae specific antibodies in circulating immune complexes in coronary heart disease. Circulation 1993; 87: 1130-4.
18. Baudner S, Dati F. Standardisierung der Bestimmung von 14 Proteinen in Human-Serum auf der Basis des neuen IFCC/BCR/CAP internationalen Referenzmaterials CRM 470. J Lab Med 1996; 20: 145-52.
19. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. 1. The Analysis of Case-Control Studies. Lyon. IARC. Scientific Publications 32, 1980.
20. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-6.
21. Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998; 26: 719-34.
22. Fletcher E, Brennan CF. Cardiac complications of Coxsackie-virus infection. Lancet 1957; 1: 913-5.
23. Burch GE, Tsui CY, Harb JM. Pathologic changes of aorta and coronary arteries of mice infected with Coxsackie B4 virus (35641). Proc Soc Exp Biol Med 1971; 137: 657-61.
24. Woods JD, Nimmo MJ, Mackay-Scollay EM. Acute transmural myocardial infarction associated with active Coxsackie virus B infection. Am Heart J 1975; 89: 283-7.
25. Nicholls AC, Thomas M. Coxsackie virus infection in acute myocardial infarction. Lancet 1977; 1: 883-4.
26. Nikoskelainen J, Kalliomäki JL, Lapinleimu K, Stenvik M, Halonen PE. Coxsackie B virus antibodies in myocardial infarction. Acta Med Scand 1983; 214: 29-32.
27. Griffiths PD, Hannigton G, Booth JC. Coxsackie B virus infections and myocardial infarction. Results from a prospective, epidemiologically controlled study. Lancet 1980; 1: 1387-9.
28. Pönkä A. Carditis associated with Mycoplasma pneumoniae infection. Acta Med Scand 1979; 206: 77-86.
29. Karjalainen J, Heikkilä J, Nieminen MS, et al. Etiology of mild acute infectious myocarditis. Acta Med Scand 1983; 213: 65-73.
30. Pönkä A, Jalanko H, Pönkä T, Stenvik M. Viral and mycoplasmal antibodies in patients with myocardial infarction. Ann Clin Res 1981; 13: 429-32.
31. Dowd AB, Grace R, Rees WDW. Cerebral infarction associated with Mycoplasma pneumoniae infection. Lancet 1987; 2: 567.
32. Gurfinkel EP, Rozlosnik J, Bozovich G, Duronto E, Dos Santos A. Mautner B. IgG antibodies to chlamydial and mycoplasma infection plus C-reactive protein related to poor outcome in unstable angina. Arch Inst Cardiol Mex 1997; 67: 462-8.
33. Maraha B, van der Zee A, Bergmans AMC, et al. Is Mycoplasma pneumoniae associated with vascular disease? J Clin Microbiol 2000; 38: 935-6.
34. Higuchi ML, Sambiase N, Palomino S, et al. Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz J Med Biol Res 2000; 33: 1023-6.
35. Danesh J, Whincup P, Walker M, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective stud and meta-analysis. BMJ 2000; 321: 208-13.
36. Epstein SE, Zhou YI, Zhu J. Infection and atherogenesis. Emerging mechanistic paradigms. Circulation 1999; 100: e20-8.
37. Zhu J, Nieto J, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction and death. Circulation 2001; 103: 45-51.
38. Rupprecht HJ, Blankenberg S, Bickel C, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001; 104: 25-31.